Brightsurf Science News & Current Events

April 05, 2000
Researchers find key to growing, differentiating human cells
Researchers have taken the first step toward differentiating human cells in an artificial growth medium.

Media advisory: geomagnetic storm alert
The U.S. Geological Survey (USGS) reports a sudden increase in geomagnetic activity that may signal the onset of a geomagnetic storm.

AVAX Technologies receives an additional $3.0 Million (AUD) investment in Australian joint venture from Australian Vaccine Technologies Ltd.
AVAX Technologies, Inc. today announced that its Australian joint venture, AVAX Australia Pty.

Rush seeking patients with psoriatic arthritis for drug trial
Patients with psoriatic arthritis are being sought to participate in a drug trial at Rush-Presbyterian-St.

'Unprecedented' tobacco industry campaign undermined report on second-hand smoke and cancer, researchers said
A ten-year study conducted by the International Agency for Research in Cancer (IARC) examining the links between second- hand smoke and cancer was subverted by an unprecedented misinformation campaign coordinated by the tobacco industry and resulting in misleading media reports of the European scientific study even before it was published.

Bionumerik reports data on two novel supercomputer engineered anticancer agents
BioNumerik Pharmaceuticals, presented data at AACR two novel high performance computer engineered agents, BNP7787 and Karenitecin, that have been designed to help address common and important unmet needs in cancer therapy.

UNC-CH bus brings mobile lab, high-tech science focus to underserved N.C. schools
The University of North Carolina at Chapel Hill next week will launch a new traveling science laboratory that will bring the latest technology and teaching tools to North Carolina schools lacking science resources.

Vion's Tapet® demonstrates superior anticancer efficacy
VION PHARMACEUTICALS, INC. and Yale University presented preclinical data at the AACR that although Vion's unarmed TAPET® bacteria and radiotherapy alone slowed tumor growth and prolonged survival, the combination of the two prolonged survival as much as 50% over the best results obtained with radiotherapy alone.

Nobel Laureate creates potent anticancer weapons
Two anticancer drugs, ecteinascidin and phthalascidin, each estimated to be at least 100 times more powerful than current anticancer medication Taxol®, have been synthesized by Nobel Laureate Elias Corey.

Low voltage, high bandwidth telecommunications device reported in Science
Researchers create a device that operates on less than one volt and can convert electric signals into optical transmissions at a rate of 100 gigabytes of information per second.

BioMed Central to free scientists and clinical researchers from copyright restrictions
Researchers will be free from the restrictive copyright agreements usually imposed by scientific journals thanks to a groundbreaking move announced by a new publishing house today.

The Role and Activities of Scientific Societies in Promoting Research Integrity: Conference to be held April 10-11
At a special conference to be held on April 10-11 at the American Association for the Advancement of Science, scientific society staff, officers, and members, legal scholars, ethicists, and social scientists will discuss current ethics codes, what societies are doing to promote research integrity, and how these efforts can be improved.

Harvard e-commerce study shows retailers may face less price competition online
Contrary to prevailing opinion, companies that sell products online may actually face less price competition and charge higher prices, especially for products that must be examined in stores before purchase, according to a study published in a journal of the Institute for Operations Research and the Management Sciences (INFORMS®).

Attending religious activities may help delay sexual activity, according to recent study
Parents who take their families to religious services regularly may be helping their children develop aspects of spirituality that are associated with the choice not to become sexually active, according to a recent study published in the April issue of the Journal of Adolescent Health.

Search for taste receptors yields sweet success
Using biochemical clues as a guide to scout massive databases of genetic sequences, HHMI researchers have identified a family of candidate genes in humans and mice that code for receptors that sense bitter-tasting chemicals.

Blood-thinning drug's benefit in stroke prevention extends to elderly with irregular heartbeat
Using a blood-thinning drug in elderly people with an irregular heartbeat may provide stroke- preventing benefits that had previously been found only in younger people, according to a report in today's Stroke: Journal of the American Heart Association.

New class of drugs for erectile dysfunction unveiled
Scientists at Bristol-Myers Squibb have identified a promising new class of drugs that may yield strong candidates for the treatment of erectile dysfunction (also known as impotence) that may be more potent and have fewer side effects than the popular Viagra®, they say.

Adding acetone to compost remediates chunk TNT contaminated soil
Like the Wicked Witch of the West, another danger can be melted away, only this time it's with a bucket of fingernail polish remover.

New anti-tumor drug promising in animal studies, UF research shows
A drug that indirectly attacks tumors by destroying the blood vessels that feed them substantially boosts the effectiveness of traditional anti-cancer medications in laboratory animals, new University of Florida research shows.

Rewiring the damaged brain
A study by Adelaide University scientists suggesting that the brain can be 'rewired' could lead to a new therapy for stroke victims.

VION and Yale University present preclinical data on novel sulfonyl hydrazine anticancer agent
VION PHARMACEUTICALS and Yale University presented data on new anticancer agent VNP40101M (Sulfonyl Hydrazine Prodrug class), demonstrating broad antitumor activity against leukemia, melanoma, lung/colon carcinomas in animal models.

UCSF Cancer Center part of study to help reduce cancer among Asian Americans
The percentage increase in Asian Americans who are dying of cancer is growing faster than for any other ethnic group.

'Opto-chips' are high-speed communications breakthrough
New polymers developed by chemists and engineers at the University of Washington and the University of Southern California appear to achieve speed and capacity increases so great that they will revolutionize telecommunications, data processing, sensing and display technologies.

Infant hearing screening program detects hearing loss at significantly early age
Results of a New York State infant hearing screening project, published in the April 2000 issue of Ear and Hearing, show that universal newborn hearing screening programs can help meet national goals for identification of and intervention for hearing impairment, says Syracuse University associate professor Beth Prieve.

Scientists, research advocates honored as Albert B. Sabin Heroes of Science
Americans for Medical Progress will present Albert B. Sabin Hero of Science Awards Thursday evening to six individuals who have made significant contributions to biomedical research: Dave & Lynn Frohnmayer of the Fanconi Anemia Research Fund; vaccine pioneer Maurice R. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to